NCT06237348View on ClinicalTrials.gov

Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 15, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Non-cystic Fibrosis BronchiectasisChronic Mucus Hypersecretion
Interventions
DEVICE

Simeox

Daily airway clearance therapy at home during 2 months

COMBINATION_PRODUCT

Control

Daily airway clearance therapy at home during 2 months

Trial Locations (2)

30-688

Jagiellonian University Medical College, Krakow

90-153

N. Barlicki University Hospital No 1, Lodz

All Listed Sponsors
collaborator

Medical University of Lodz

OTHER

collaborator

University Hospital in Krakow

OTHER

lead

Physio-Assist

INDUSTRY

NCT06237348 - Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH | Biotech Hunter | Biotech Hunter